From 10:15 on Tuesday 17 March
the House of Lords Science and Technology
Committee continues
its new inquiry into innovation in the NHS, with a
particular focus on personalised medicine and the use
of artificial intelligence.
The Committee will hear
from:
10:15
-
Professor Florian Markowetz,
Professor of Computational Oncology, University of Cambridge
and Senior Leader, Cancer Research UK Cambridge
Institute
11.15
-
Rich
Scott, CEO, Genomics
England
The evidence session will take
place in Committee Room 4, Palace of Westminster and will be
available to watch live from 10.15 or on demand
on Parliamentlive.tv.
Background:
Personalised medicines refer to
tailoring medical treatment to the individual characteristics of
each patient such as using genetic information
to provide personalised preventative advice, diagnosis,
and therapies. Recent advances in genomics, AI-driven data
analytics and biotechnology are driving this evolution, enabling
new therapies like CAR (Chimeric Antigen Receptor) T-cell
therapy, offer life-saving potential, but the need to tailor
them to the individual can make them expensive to
deploy.
There are
broad Government ambitions to use AI more widely to
advance medical science; but translating the cutting edge of medical
science into routine patient delivery in the
NHS remains a
challenge.
The Committee invites written contributions to its
inquiry by 23.59 on Monday 20
April 2026.
